• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

路易体痴呆的血清蛋白质组学分析:表面增强激光解吸电离飞行时间质谱分析的诊断潜力

Serum proteomic profiling of dementia with Lewy bodies: diagnostic potential of SELDI-TOF MS analysis.

作者信息

Wada-Isoe K, Michio K, Imamura K, Nakaso K, Kusumi M, Kowa H, Nakashima K

机构信息

Department of Neurology, Faculty of Medicine, Institute of Neurological Sciences, Tottori University, Yonago, Japan.

出版信息

J Neural Transm (Vienna). 2007;114(12):1579-83. doi: 10.1007/s00702-007-0794-5. Epub 2007 Aug 10.

DOI:10.1007/s00702-007-0794-5
PMID:17690946
Abstract

Dementia with Lewy bodies (DLB) is the second most common senile degenerative dementia after Alzheimer's disease (AD). The presentation of overlapping symptoms between these two disorders leads to difficulties in the determination of clinical entities. Serum samples were subjected to surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) analysis in order to identify a diagnostic marker for DLB. Four putative protein peaks (m/z 3,883, 4,964, 7,761 and 10,534) were differentially expressed in DLB patients compared to AD patients and control subjects. Receiver operating characteristics (ROC) analysis of a multivariate logistic model of the combination of three peaks (m/z 3,883, 7,761 and 10,534) exhibited the highest discriminatory ability of DLB subjects from non-DLB subjects with a sensitivity of 83.3%, a specificity of 95.8%, a positive predictive value of 90.9% and a negative predictive value of 92.0%. SELDI-TOF MS profiling, therefore, has revealed a serum signature with high diagnostic potential for DLB.

摘要

路易体痴呆(DLB)是仅次于阿尔茨海默病(AD)的第二常见的老年性退行性痴呆。这两种疾病之间重叠症状的表现导致临床实体的确定存在困难。为了鉴定DLB的诊断标志物,对血清样本进行了表面增强激光解吸/电离飞行时间质谱(SELDI-TOF MS)分析。与AD患者和对照受试者相比,DLB患者中有四个假定的蛋白峰(m/z 3,883、4,964、7,761和10,534)差异表达。对三个峰(m/z 3,883、7,761和10,534)组合的多变量逻辑模型进行的受试者工作特征(ROC)分析显示,区分DLB受试者与非DLB受试者的能力最高,灵敏度为83.3%,特异性为95.8%,阳性预测值为90.9%,阴性预测值为92.0%。因此,SELDI-TOF MS分析揭示了一种对DLB具有高诊断潜力的血清特征。

相似文献

1
Serum proteomic profiling of dementia with Lewy bodies: diagnostic potential of SELDI-TOF MS analysis.路易体痴呆的血清蛋白质组学分析:表面增强激光解吸电离飞行时间质谱分析的诊断潜力
J Neural Transm (Vienna). 2007;114(12):1579-83. doi: 10.1007/s00702-007-0794-5. Epub 2007 Aug 10.
2
Serum peptides as candidate biomarkers for dementia with Lewy bodies.血清肽作为路易体痴呆的候选生物标志物。
Int J Geriatr Psychiatry. 2015 Dec;30(12):1195-206. doi: 10.1002/gps.4274. Epub 2015 Mar 6.
3
A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.一种使用表面增强激光解吸电离质谱法检测结肠直肠癌的血清蛋白质组模式。
Cancer Invest. 2006 Dec;24(8):747-53. doi: 10.1080/07357900601063873.
4
Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.胆管癌的蛋白质组学分析:表面增强激光解吸电离飞行时间质谱在恶性胆管狭窄中的诊断潜力
Hepatology. 2006 Sep;44(3):658-66. doi: 10.1002/hep.21294.
5
Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.肝细胞癌和慢性肝病中的血清蛋白质组学与生物标志物
Clin Cancer Res. 2008 Jan 15;14(2):470-7. doi: 10.1158/1078-0432.CCR-07-0586.
6
Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.表面增强激光解吸/电离质谱分析:乙肝相关肝细胞癌的新诊断方法。
J Gastroenterol Hepatol. 2009 Jan;24(1):55-62. doi: 10.1111/j.1440-1746.2008.05580.x. Epub 2008 Sep 24.
7
Application of serum SELDI proteomic patterns in diagnosis of lung cancer.血清表面增强激光解吸电离飞行时间质谱蛋白质组学图谱在肺癌诊断中的应用。
BMC Cancer. 2005 Jul 20;5:83. doi: 10.1186/1471-2407-5-83.
8
[Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].[表面增强激光解吸/电离飞行时间质谱法检测乳腺癌血清蛋白质组图谱及其临床意义]
Zhonghua Zhong Liu Za Zhi. 2006 Mar;28(3):204-7.
9
A serum protein signature with high diagnostic value in bacterial endocarditis: results from a study based on surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.一种在细菌性心内膜炎中具有高诊断价值的血清蛋白标志物:基于表面增强激光解吸/电离飞行时间质谱分析的研究结果
J Infect Dis. 2006 Nov 15;194(10):1356-66. doi: 10.1086/508429. Epub 2006 Oct 11.
10
Application of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry coupled with an artificial neural network model for the diagnosis of hepatocellular carcinoma.表面增强激光解吸/电离飞行时间质谱联用人工神经网络模型在肝细胞癌诊断中的应用
Hepatogastroenterology. 2012 Sep;59(118):1902-6. doi: 10.5754/hge11771.

引用本文的文献

1
Identification of cysteinylated transthyretin, a predictive biomarker of treatment response to partially hydrolyzed guar gum in type 2 diabetes rats, by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.通过表面增强激光解吸/电离飞行时间质谱法鉴定半胱氨酸化甲状腺素运载蛋白,其为2型糖尿病大鼠对部分水解瓜尔胶治疗反应的预测生物标志物。
J Clin Biochem Nutr. 2016 Jan;58(1):23-33. doi: 10.3164/jcbn.15-98. Epub 2015 Dec 8.
2
Biomarkers in biological fluids for dementia with Lewy bodies.用于路易体痴呆的生物流体中的生物标志物。
Alzheimers Res Ther. 2014 Oct 16;6(5-8):72. doi: 10.1186/s13195-014-0072-3. eCollection 2014.
3

本文引用的文献

1
Biomarker discovery from body fluids using mass spectrometry.利用质谱技术从体液中发现生物标志物。
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 15;849(1-2):105-14. doi: 10.1016/j.jchromb.2006.09.017. Epub 2006 Nov 9.
2
Assessing the utility of SELDI-TOF and model averaging for serum proteomic biomarker discovery.评估表面增强激光解吸电离飞行时间质谱(SELDI-TOF)及模型平均法在血清蛋白质组生物标志物发现中的效用。
Proteomics. 2006 Dec;6(24):6405-15. doi: 10.1002/pmic.200600420.
3
A serum protein signature with high diagnostic value in bacterial endocarditis: results from a study based on surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease.
阿尔茨海默病中 U1 小核核糖核蛋白复合物和 RNA 剪接改变。
Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16562-7. doi: 10.1073/pnas.1310249110. Epub 2013 Sep 10.
4
Bridging molecular genetics and biomarkers in lewy body and related disorders.连接路易体及相关疾病中的分子遗传学与生物标志物
Int J Alzheimers Dis. 2011;2011:842475. doi: 10.4061/2011/842475. Epub 2011 Jul 3.
5
Cerebrospinal fluid biomarkers for dementia with lewy bodies.用于路易体痴呆的脑脊液生物标志物。
Int J Alzheimers Dis. 2010 Oct 17;2010:536538. doi: 10.4061/2010/536538.
一种在细菌性心内膜炎中具有高诊断价值的血清蛋白标志物:基于表面增强激光解吸/电离飞行时间质谱分析的研究结果
J Infect Dis. 2006 Nov 15;194(10):1356-66. doi: 10.1086/508429. Epub 2006 Oct 11.
4
Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry.临床蛋白质组学:利用表面增强激光解吸电离飞行时间质谱寻找更好的肿瘤标志物。
Trends Pharmacol Sci. 2006 May;27(5):251-9. doi: 10.1016/j.tips.2006.03.003. Epub 2006 Apr 4.
5
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.轻度认知障碍患者脑脊液生物标志物与早期阿尔茨海默病的关联:一项随访研究。
Lancet Neurol. 2006 Mar;5(3):228-34. doi: 10.1016/S1474-4422(06)70355-6.
6
Identification of potential CSF biomarkers in ALS.肌萎缩侧索硬化症潜在脑脊液生物标志物的鉴定
Neurology. 2006 Apr 25;66(8):1218-22. doi: 10.1212/01.wnl.0000203129.82104.07. Epub 2006 Feb 15.
7
Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.使用表面增强激光解吸/电离飞行时间质谱蛋白质芯片方法发现类风湿性关节炎新生物标志物。
Arthritis Rheum. 2005 Dec;52(12):3801-12. doi: 10.1002/art.21607.
8
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.路易体痴呆的诊断与管理:DLB联盟的第三次报告
Neurology. 2005 Dec 27;65(12):1863-72. doi: 10.1212/01.wnl.0000187889.17253.b1. Epub 2005 Oct 19.
9
Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.路易体痴呆、伴或不伴痴呆的帕金森病以及阿尔茨海默病的脑三维单光子发射计算机断层扫描(3D-SSP SPECT)分析
Clin Neurol Neurosurg. 2005 Aug;107(5):396-403. doi: 10.1016/j.clineuro.2004.12.005. Epub 2005 Jan 19.
10
Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases.心脏脂肪酸结合蛋白作为神经退行性疾病的潜在诊断标志物。
Neurosci Lett. 2004 Nov 3;370(1):36-9. doi: 10.1016/j.neulet.2004.07.061.